UK markets open in 12 minutes

Standard BioTools Inc. (FLB.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.2800+0.0200 (+0.88%)
At close: 08:01AM CEST
Full screen
Previous close2.2600
Open2.2800
Bid2.3200 x 50000
Ask2.3400 x 50000
Day's range2.2800 - 2.2800
52-week range1.3300 - 2.8000
Volume2
Avg. volume0
Market cap873.313M
Beta (5Y monthly)1.64
PE ratio (TTM)N/A
EPS (TTM)-0.8800
Earnings date08 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.00
  • GlobeNewswire

    Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

    Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency and reduce operating costs, while suppo

  • GlobeNewswire

    Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

    SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the market. The Company’s management will host a conference call and webcast at 1:30 p.m. PT, 4:30 p.m. ET, on May 8, 2024, to discuss first quarter 2024 financial results and operational progress. A press release including the financial res

  • Simply Wall St.

    Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?

    We feel now is a pretty good time to analyse Standard BioTools Inc.'s ( NASDAQ:LAB ) business as it appears the company...